LexisNexis Risk Solutions Launches Research-Ready Healthcare Data Blends to Expedite Research

Rhea-AI Summary

LexisNexis Risk Solutions has announced the launch of new research-ready, real-world healthcare datasets designed to accelerate research timelines and reduce costs. The solution uses referential-based tokenization to create blended, patient-level datasets that are standardized and research-ready.

The data blends combine multiple datasets including:

• Care Delivery Insights with medical, pharmacy, and lab claims
• Financial insights on total care costs
• Social determinants of health (SDOH) factors
• Mortality Insights updated weekly

The integrated datasets provide a longitudinal view across all care settings and populations, enabling researchers to identify distinct patient populations, reduce potential biases, and support proactive monitoring of high-risk populations. This initiative aims to help research teams create more holistic and unbiased datasets to uncover health disparities and develop personalized treatments.

Positive

• Launch of new revenue-generating healthcare analytics product
• Product addresses multiple market segments (research, clinical, financial)
• Competitive advantage through proprietary tokenization technology
• Expansion of existing healthcare analytics portfolio

Negative

• None.

Blended, patient-level datasets leveraging proprietary tokenization technology simplify data enrichment while adhering to privacy standards

ATLANTA, Jan. 29, 2025 /PRNewswire/ -- LexisNexis® Risk Solutions, a leading provider of healthcare analytics and insights, today announced the launch of new research-ready, real-world datasets designed to accelerate research timelines, reduce costs and enable more equitable analyses. Using referential-based tokenization, the patient-level datasets are blended, expert determined and certified ensuring they are standardized and research ready. This process gives research teams a more simplified way to enrich their datasets or define a cohort of interest to support specific study objectives, including benchmarking with comparator cohorts. These datasets integrate into clinical research workflows, generating impactful real-world evidence to accelerate innovation and speed-to-market.

"By offering comprehensive, research-ready datasets that are standardized, expert determined and ready for immediate use, we're enabling researchers to eliminate traditional data management challenges and accelerate their timeline to deliver actionable insights," said Adam Mariano, president and general manager of healthcare, LexisNexis Risk Solutions. "We're empowering research teams with a more efficient way to create more holistic and unbiased datasets, so they can uncover health disparities, develop personalized treatments, and ultimately improve patient outcomes across diverse populations."

The new, expert determined data blends include two or more of the following datasets:

• Care Delivery Insights: 
  • Healthcare utilization insights from de-identified open and closed medical, pharmacy and lab claims including diagnoses, comorbidities, service date, place of service, service codes and modifiers
  • Pharmacy/medication insights, including drug name, code, quantity and dosage
  • Financial insights, including details on the total cost of care
• Social determinants of health (SDOH):
  • Factors such as transportation risks, financial challenges and proximity to care
  • Insights on disparities in healthcare access based on urban/rural settings, food deserts, and race/ethnicity
• Mortality Insights: 
  • Derived from non-traditional sources and updated weekly

The data blends also provide a longitudinal view across all settings of care and all populations, reducing potential biases from single-source data. Advanced subgroup analyses enable researchers to identify distinct patient populations with unique treatment responses, fostering personalized care and more effective therapeutics and care delivery models. Furthermore, the data blends support proactive monitoring to identify high-risk populations, reduce adverse events, and facilitate patient assistance programs by addressing financial and logistical challenges.

For more information about the new research-ready datasets, visit https://risk.lexisnexis.com/.

About LexisNexis Risk Solutions
LexisNexis Risk Solutions harnesses the power of data and advanced analytics to provide insights that help businesses and governmental entities reduce risk and improve decisions to benefit people around the globe. We provide data and technology solutions for a wide range of industries including insurance, financial services, healthcare and government. Headquartered in metro Atlanta, Georgia, we have offices throughout the world and are part of RELX (LSE: REL/NYSE: RELX), a global provider of information and analytics for professional and business customers. For more information, please visit www.risk.lexisnexis.com and www.relx.com.

Media Contact: 
Syed Shabbir
Sr. Manager, Corporate Communications
LexisNexis Risk Solutions  
816-572-7709  
syed.shabbir@lexisnexisrisk.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/lexisnexis-risk-solutions-launches-research-ready-healthcare-data-blends-to-expedite-research-302362719.html

SOURCE LexisNexis Risk Solutions

FAQ

What new healthcare datasets did LexisNexis Risk Solutions (RELX) launch in January 2024?

LexisNexis Risk Solutions launched research-ready, real-world datasets that combine care delivery insights, financial data, social determinants of health, and mortality insights, using proprietary tokenization technology for healthcare research and analysis.

How does the new LexisNexis (RELX) healthcare data blend technology work?

The technology uses referential-based tokenization to create standardized, expert-determined patient-level datasets that blend multiple data sources while maintaining privacy standards.

What types of healthcare data are included in LexisNexis's (RELX) new research-ready datasets?

The datasets include care delivery insights, pharmacy/medication data, financial insights, social determinants of health (SDOH), and weekly-updated mortality insights from various sources.

How will LexisNexis's (RELX) new healthcare datasets benefit researchers?

The datasets will help accelerate research timelines, reduce costs, enable more equitable analyses, and allow researchers to identify distinct patient populations and develop personalized treatments.

What are the key features of LexisNexis's (RELX) healthcare data blends for research?

Key features include longitudinal view across all care settings, reduced data bias, advanced subgroup analyses, and proactive monitoring capabilities for high-risk populations.